Comparison of Insulin Pump and MDI for Pregestational Diabetes During Pregnancy

NCT02064023 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-10-30

No results posted yet for this study

Summary

This study is investigating whether insulin treatment with the insulin pump or with multiple daily injections (MDI) gives better outcomes for mother and baby in pregnant women with pregestational diabetes. Participants will be randomized to use either the insulin pump or MDI.

Conditions

Interventions

DEVICE

insulin pump

subjects in the experimental arm will administer insulin using a pump

OTHER

multiple daily insulin injection

Subjects will continue with usual insulin injections

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • David M Thompson, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-12-04
Completion
2015-12-04

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02064023 on ClinicalTrials.gov